Word abonnee en neem Beursduivel Premium
Rode planeet als pijlen grid met hoorntjes Beursduivel

ACCSYS TECHNOLOGIES PLC Terug naar discussie overzicht

Accsys CFO: we moeten 1.000 - 1.200 extra mensen aannemen

6 Posts
| Omlaag ↓
  1. [verwijderd] 10 juli 2012 08:24
    Accsys CFO: we moeten 1.000 - 1.200 extra mensen aannemen

    (MORE TO FOLLOW) Dow Jones Newswires
    July 10, 2012 02:10 ET (06:10 GMT)
    Copyright (c) 2012 Dow Jones & Company, Inc.
  2. [verwijderd] 10 juli 2012 08:31
    Source

    07:00
    Accsys Technologies - Annual Results
    RNS
    RNS Number : 2678H
    Accsys Technologies PLC
    10 July 2012

    ?

    Regulatory Announcement
    Company
    Accsys Technologies PLC


    TIDM
    AXS
    Headline
    Preliminary Announcement of Results for the year ended 31 March 2012
    Released
    10 July 2012
    Number

    AIM: AXS
    NYSE Euronext Amsterdam: AXS
    10 July 2012

    ACCSYS TECHNOLOGIES PLC
    ("Accsys" or the "Company")
    Preliminary Announcement of Results for the year ended 31 March 2012

    Accsys, the environmental science and wood technology company, has made significant progress during the year towards delivering on its strategy of licensing its technology and seeding new markets with its sustainable and highly durable modified wood products.

    Operational Highlights:

    • Licence agreement signed in June 2012 with Solvay-Rhodia ('Solvay') for the production and sale of Accoya® wood using Accsys' proprietary acetylation technology. The conditional agreement grants Solvay exclusive rights to produce and sell Accoya® within certain countries in Europe;

    • Introduction of Medite Tricoya® to the market place with first sales to customers from our joint development partner, Medite, opening up a wealth of new potential applications;

    • Signed licence option agreement in April 2012 with a leading MDF and Particle Board manufacturer in Latin America which we expect to open up significant new opportunities;

    • Strategic collaborative relationship agreed with BP in March 2012 which includes the supply of acetic anhydride and the support of further product and application developments;


    • Significantly strengthened intellectual property portfolio. We are pleased to announce this includes the recent grant of a product patent for Accoya® in the UK, securing monopoly rights for Accoya® in the United Kingdom for 20 years;

    • Completed first part of sale and leaseback of Arnhem land and buildings, generating proceeds of €2.2m and which will also enable future improvements to wood handling logistics and storage facilities;

    • Eight further Accoya® distribution, agency and supply agreements signed, making a total of 35, covering most of Europe, Australia, Canada, Chile, China, India, Korea, Lebanon, Morocco, New Zealand, parts of South-East Asia, U.A.E and the USA; and

    • Introduction of Accoya® Alder to our product line; a popular, attractive hardwood species which provides superior performance, similar to that of Accoya® Radiata.



    Financial Highlights

    · 10% increase in revenue for the financial year to €15.0m (2011: €13.7m). Revenue for the second half of the financial year increased by 41% compared to the first half of the year as a result of increased demand for Accoya®;
    · Improvement in gross manufacturing margin from a 4% loss last year to a 0.3% loss and from a 7% loss in the first half of the financial year to a 5% profit in the second half;
    · Exceptional impairment charge of €2.3m in respect of licensee receivables consisting of €2.9m non-cash charge relating to Al Rajhi as a result of continuing uncertainty as to whether the licence will continue, partly offset by €0.6m of technology fees paid by Diamond Wood which had previously been provided for;
    · 9% reduction in other operating costs to €12.5m (2011: €13.7m);
    · 17% improvement in profit after tax before exceptional items to a loss of €12.1m (2011: €14.6m). (Including exceptional items, profit after tax improved by 1% to a loss of €14.4m (2011: €14.4m);
    · Cash balance of €24.6m as at 31 March 2012 (2011: €27.6m); and
    · 79% reduction in net cash out-flows from operating activities to €3.7m (2011: €17.7m) as result of improved cost and working capital controls, including a significant reduction in inventory levels.

    There will be a presentation relating to these results at 09:30 BST on Tuesday 10th July 2012. The presentation will take the form of a web based conference call, details of which are below:

    Webcast link: Click Here or copy and paste ALL of the following text into your browser:

    www.media-server.com/m/p/9969zs9d

    Conference call details for participants:

    Participant Telephone Number: +44 (0)20 3364 5381 UK Toll
    Confirmation Code: 8496820

    Participants will have to quote the above code when dialling into the conference.

    Paul Clegg, CEO of Accsys, commented:

    "I am pleased with the excellent progress we have made in the last year towards delivering on our long-term strategy of seeding the market and developing licensing and strategic opportunities whilst continuing to maintain our focus on working capital management.

    It was a pleasure to be able to recently disclose the identity of our prospective licensee, Solvay, with whom we have been working closely for some time. The Accoya® licence agreement reflects a significant amount of work from Accsys and Solvay and represents a commitment to the next stage in the successful commercialisation of Accoyaand its acceptance as the globally recognised leading high technology, high performance, modified wood.

    The significant progress made this year in developing Tricoya® also marks an important milestone in the Company's development. We expect that the commercial launch of Medite Tricoya® by our Joint Development Partner Medite, followed by the licence option agreement for the South American market will be the first steps towards making Tricoya® the first new global, truly innovative panel product for many years.

    Sales of Accoya® have grown despite the challenging economic climate and I am confident the progress we have made in building the brand, product development and increasing the distribution network has left us in a strong position to continue to increase sales going forwards. I expect that the increasing demand for our Accoya® wood product will result in the plant breaking even and the Company ultimately generating profit, even without taking account of any licence income."

    The financial statements for the year ended 31 March 2012 follow:

    Chairman's Statement
  3. drulletje drie 10 juli 2012 08:34
    quote:

    xblue schreef op 10 juli 2012 08:24:

    Accsys CFO: we moeten 1.000 - 1.200 extra mensen aannemen
    Over ASML staat hetzelfde zal het niet over hun gaan?

    *CORRECT: ASML CFO we moeten 1.000 - 1.200 extra mensen aannemen
  4. drulletje drie 10 juli 2012 08:36
    Accsys boekt meer omzet in 2011/2012


    Door Levien de Feijter

    Van DOW JONES NIEUWSDIENST


    AMSTERDAM (Dow Jones)--Houttechnologiebedrijf Accsys Technologies plc (AXS.LN) heeft in het fiscale boekjaar 2011/12 meer omzet behaald, terwijl de kaspositie licht verslechterde. Dat meldt de onderneming dinsdag in een persbericht over de voorlopige jaarcijfers.

    In het boekjaar dat eindigde op 30 maart 2012 steeg de omzet met 10% tot EUR15,0 miljoen van EUR13,7 miljoen een jaar eerder. De kaspositie van het bedrijf dat technologie ontwikkelt voor de verduurzaming van hout bedroeg eind maart EUR24,6 miljoen ten opzichte van EUR27,6 miljoen een jaar eerder.

    Vooruitkijkend verwacht Accsys dat de omzet uit de verkoop van Accoya hout sneller zal groeien dan in het afgelopen boekjaar.

    Het aandeel is maandag gesloten op EUR0,18.


    Door Levien de Feijter; Dow Jones Nieuwsdienst: +31-20-5715200; levien.defeijter@dowjones.com


    (END) Dow Jones Newswires

    July 10, 2012 02:28 ET (06:28 GMT)

    Copyright (c) 2012 Dow Jones & Company, Inc.

6 Posts
|Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Beursduivel.be

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.108
AB InBev 2 5.538
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 52.120
ABO-Group 1 23
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 267
Accsys Technologies 23 10.852
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 192
Adecco 1 1
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.824
Aedifica 3 926
Aegon 3.258 323.067
AFC Ajax 538 7.088
Affimed NV 2 6.305
ageas 5.844 109.903
Agfa-Gevaert 14 2.062
Ahold 3.538 74.349
Air France - KLM 1.025 35.280
AIRBUS 1 12
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.050
Alfen 16 25.244
Allfunds Group 4 1.517
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 418
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.826
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.837 243.812
AMG 971 134.312
AMS 3 73
Amsterdam Commodities 305 6.745
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 496
Antonov 22.632 153.605
Aperam 92 15.053
Apollo Alternative Assets 1 17
Apple 5 386
Arcadis 252 8.802
Arcelor Mittal 2.034 320.958
Archos 1 1
Arcona Property Fund 1 287
arGEN-X 17 10.350
Aroundtown SA 1 221
Arrowhead Research 5 9.750
Ascencio 1 28
ASIT biotech 2 697
ASMI 4.108 39.600
ASML 1.766 109.937
ASR Nederland 21 4.511
ATAI Life Sciences 1 7
Atenor Group 1 522
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.893
Axsome Therapeutics 1 177
Azelis Group 1 67
Azerion 7 3.449

Macro & Bedrijfsagenda

  1. 26 maart

    1. Economische groei Q4 2e raming (NL)
    2. Consumenten- en producentenprijzen februari (VK)
    3. Consumentenvertrouwen maart (Fra)
    4. Randstad - Jaarvergadering
    5. Hypotheekaanvragen - wekelijks (VS)
    6. Orders voor duurzame goederen februari (VS)
    7. Olievoorraden - wekelijks (VS)
  2. 27 maart

    1. Exor Q4-cijfers
    2. Sligro Q4-cijfers
    3. Hennes & Mauritz Q1-cijfers
de volitaliteit verwacht indicator betekend: Market moving event/hoge(re) volatiliteit verwacht